Education
About Us
Working with TipRanks
Follow Us
Taiko Pharmaceutical Co., Ltd. (JP:4574)
:4574
4574 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥228.00 - ¥495.00
Previous CloseN/A
Volume146.60K
Average Volume (3M)210.27K
Market Cap
¥12.17B
Enterprise Value¥19.63B
Total Cash (Recent Filing)¥4.53B
Total Debt (Recent Filing)¥2.03B
Price to Earnings (P/E)17.0
Beta0.89
Next Earnings
Aug 08, 2025EPS EstimateN/A
Last Dividend Ex-Date
Dec 29, 2020Dividend YieldN/A
Share Statistics
EPS (TTM)5.83
Shares Outstanding50,636,900
10 Day Avg. Volume107,080
30 Day Avg. Volume210,273
Financial Highlights & Ratios
PEG Ratio0.68
Price to Book (P/B)1.53
Price to Sales (P/S)0.00
P/FCF Ratio21.56
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Taiko Pharmaceutical Co., Ltd. News
PremiumCompany Announcements
Taiko Pharmaceutical Reports Decline in Q1 2025 Financial Results
PremiumCompany Announcements
Taiko Pharmaceutical Reports Strong Financial Turnaround in 2024Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
―
Mutual Funds
― Other Institutional Investors
99.94% Public Companies and
Individual Investors
4574 FAQ
What was Taiko Pharmaceutical Co., Ltd.’s price range in the past 12 months?
Taiko Pharmaceutical Co., Ltd. lowest stock price was ¥228.00 and its highest was ¥495.00 in the past 12 months.
What is Taiko Pharmaceutical Co., Ltd.’s market cap?
Taiko Pharmaceutical Co., Ltd.’s market cap is ¥12.17B.
When is Taiko Pharmaceutical Co., Ltd.’s upcoming earnings report date?
Taiko Pharmaceutical Co., Ltd.’s upcoming earnings report date is Aug 08, 2025 which is in 55 days.
How were Taiko Pharmaceutical Co., Ltd.’s earnings last quarter?
Taiko Pharmaceutical Co., Ltd. released its earnings results on May 09, 2025. The company reported ¥5.83 earnings per share for the quarter, beating the consensus estimate of N/A by ¥5.83.
Is Taiko Pharmaceutical Co., Ltd. overvalued?
According to Wall Street analysts Taiko Pharmaceutical Co., Ltd.’s price is currently Overvalued.
Does Taiko Pharmaceutical Co., Ltd. pay dividends?
Taiko Pharmaceutical Co., Ltd. pays a Annually dividend of ¥10 which represents an annual dividend yield of N/A. See more information on Taiko Pharmaceutical Co., Ltd. dividends here
What is Taiko Pharmaceutical Co., Ltd.’s EPS estimate?
Taiko Pharmaceutical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Taiko Pharmaceutical Co., Ltd. have?
Taiko Pharmaceutical Co., Ltd. has 50,636,900 shares outstanding.
What happened to Taiko Pharmaceutical Co., Ltd.’s price movement after its last earnings report?
Taiko Pharmaceutical Co., Ltd. reported an EPS of ¥5.83 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.36%.
Which hedge fund is a major shareholder of Taiko Pharmaceutical Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4574
Company Description
Taiko Pharmaceutical Co., Ltd.
Taiko Pharmaceutical Co.,Ltd. engages in pharmaceuticals, infection control, and other businesses. The company manufactures and sells non-prescription drugs under the Seirogan and Seirogan Toi-A brands for the treatment of loose stools, diarrhea, food and water poisoning, vomiting, and related conditions; tablets for diarrhea; and quasi-drugs, such as Trumpet Intestinal Regulator BF. It also manufactures and sells sanitation control products under the Cleverin brand name to wholesalers, as well as Cleverin generator, a machine that emits low concentrations of chlorine dioxide gas; and supplies products using the patented Cleverin technology through OEM agreements and products developed jointly with other companies. It exports its products to the United States, Canada, Thailand, Vietnam, Malaysia, and Mongolia. Taiko Pharmaceutical Co.,Ltd. was incorporated in 1946 and is headquartered in Osaka, Japan.`
Technical Analysis
Wakamoto Pharmaceutical Co., Ltd.
―
Morishita Jintan Co., Ltd.
―
Fuso Pharmaceutical Industries,Ltd.
―
Nippon Chemiphar Co., Ltd.
―
Symbio Pharmaceuticals Limited
―